ECSP109871A - Soluciones farmacéuticas orales que contienen telbivudina - Google Patents
Soluciones farmacéuticas orales que contienen telbivudinaInfo
- Publication number
- ECSP109871A ECSP109871A EC2010009871A ECSP109871A ECSP109871A EC SP109871 A ECSP109871 A EC SP109871A EC 2010009871 A EC2010009871 A EC 2010009871A EC SP109871 A ECSP109871 A EC SP109871A EC SP109871 A ECSP109871 A EC SP109871A
- Authority
- EC
- Ecuador
- Prior art keywords
- telbivudine
- solutions containing
- oral pharmaceutical
- pharmaceutical solutions
- thymidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una solución farmacéutica adecuada para administración oral, la cual comprende ?-L-timidina/2'-desoxi-L-timidina (telbivudina), un sistema de solvente farmacéuticamente adecuado, uno o más agentes mejoradores/enmascaradores de sabor, un sistema conservador, y un sistema regulador adecuado para permitir tanto la estabilidad como la conservación del fármaco.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07112381 | 2007-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP109871A true ECSP109871A (es) | 2010-02-26 |
Family
ID=38724394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010009871A ECSP109871A (es) | 2007-07-12 | 2010-01-12 | Soluciones farmacéuticas orales que contienen telbivudina |
Country Status (22)
Country | Link |
---|---|
US (1) | US8445457B2 (es) |
EP (1) | EP2178503A1 (es) |
JP (1) | JP5314014B2 (es) |
KR (3) | KR20120078754A (es) |
CN (1) | CN101686938B (es) |
AR (1) | AR067630A1 (es) |
AU (1) | AU2008274170B2 (es) |
BR (1) | BRPI0815562A2 (es) |
CA (1) | CA2693609A1 (es) |
CL (1) | CL2008002025A1 (es) |
CO (1) | CO6270204A2 (es) |
EC (1) | ECSP109871A (es) |
IL (1) | IL202961A (es) |
MA (1) | MA31507B1 (es) |
MY (1) | MY147366A (es) |
NZ (1) | NZ582443A (es) |
PE (2) | PE20130180A1 (es) |
RU (1) | RU2493826C2 (es) |
TN (1) | TN2010000008A1 (es) |
TW (1) | TW200911302A (es) |
WO (1) | WO2009007426A1 (es) |
ZA (1) | ZA200908993B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105130967B (zh) | 2011-05-13 | 2018-04-17 | 阵列生物制药公司 | 作为trka激酶抑制剂的吡咯烷基脲和吡咯烷基硫脲化合物 |
US20140107130A1 (en) * | 2012-10-11 | 2014-04-17 | Antrim Pharmaceuticals, LLC | Oral Solution Formulations of Aripiprazole |
CR20160583A (es) | 2014-05-15 | 2017-02-23 | Array Biopharma Inc | 1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoxietil)pirrolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)urea como inhibidor de trka cinasa |
CN107708705A (zh) * | 2015-04-26 | 2018-02-16 | 林承叡 | 改善肾脏病患者的肾脏功能和/或心脏功能的方法 |
CN107550866A (zh) * | 2016-06-30 | 2018-01-09 | 康普药业股份有限公司 | 一种替比夫定制剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856364A (en) * | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
AU9186398A (en) * | 1997-09-26 | 1999-04-23 | Wakamoto Pharmaceutical Co., Ltd. | Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton |
DE19817264A1 (de) | 1998-04-18 | 1999-10-21 | Bayer Ag | Neue Dihydropyrimidine |
DE19817265A1 (de) | 1998-04-18 | 1999-10-21 | Bayer Ag | Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe |
PE20030545A1 (es) * | 2001-10-31 | 2003-06-19 | Schering Corp | Formulaciones de jarabe de ribavirina |
TWI244393B (en) * | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
US20090156545A1 (en) | 2005-04-01 | 2009-06-18 | Hostetler Karl Y | Substituted Phosphate Esters of Nucleoside Phosphonates |
-
2008
- 2008-07-10 RU RU2010104395/15A patent/RU2493826C2/ru not_active IP Right Cessation
- 2008-07-10 AR ARP080102959A patent/AR067630A1/es unknown
- 2008-07-10 CA CA2693609A patent/CA2693609A1/en not_active Abandoned
- 2008-07-10 AU AU2008274170A patent/AU2008274170B2/en not_active Ceased
- 2008-07-10 NZ NZ582443A patent/NZ582443A/en not_active IP Right Cessation
- 2008-07-10 BR BRPI0815562-3A2A patent/BRPI0815562A2/pt not_active IP Right Cessation
- 2008-07-10 KR KR1020127016214A patent/KR20120078754A/ko not_active Application Discontinuation
- 2008-07-10 PE PE2012002012A patent/PE20130180A1/es not_active Application Discontinuation
- 2008-07-10 MY MYPI20095510A patent/MY147366A/en unknown
- 2008-07-10 CN CN2008800241250A patent/CN101686938B/zh active Active
- 2008-07-10 KR KR1020147002720A patent/KR20140019040A/ko not_active Application Discontinuation
- 2008-07-10 JP JP2010515512A patent/JP5314014B2/ja not_active Expired - Fee Related
- 2008-07-10 PE PE2008001158A patent/PE20090476A1/es not_active Application Discontinuation
- 2008-07-10 EP EP08774979A patent/EP2178503A1/en not_active Withdrawn
- 2008-07-10 KR KR1020107000530A patent/KR20100029829A/ko not_active Application Discontinuation
- 2008-07-10 US US12/667,975 patent/US8445457B2/en active Active
- 2008-07-10 WO PCT/EP2008/059016 patent/WO2009007426A1/en active Application Filing
- 2008-07-11 TW TW097126552A patent/TW200911302A/zh unknown
- 2008-07-11 CL CL2008002025A patent/CL2008002025A1/es unknown
-
2009
- 2009-12-17 ZA ZA200908993A patent/ZA200908993B/xx unknown
- 2009-12-24 IL IL202961A patent/IL202961A/en not_active IP Right Cessation
-
2010
- 2010-01-07 TN TNP2010000008A patent/TN2010000008A1/fr unknown
- 2010-01-07 MA MA32485A patent/MA31507B1/fr unknown
- 2010-01-12 CO CO10002343A patent/CO6270204A2/es active IP Right Grant
- 2010-01-12 EC EC2010009871A patent/ECSP109871A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP5314014B2 (ja) | 2013-10-16 |
TN2010000008A1 (en) | 2011-09-26 |
NZ582443A (en) | 2011-04-29 |
WO2009007426A1 (en) | 2009-01-15 |
CA2693609A1 (en) | 2009-01-15 |
AU2008274170B2 (en) | 2011-06-09 |
RU2010104395A (ru) | 2011-08-20 |
MA31507B1 (fr) | 2010-07-01 |
CN101686938A (zh) | 2010-03-31 |
CN101686938B (zh) | 2012-09-05 |
KR20140019040A (ko) | 2014-02-13 |
CL2008002025A1 (es) | 2009-05-08 |
AR067630A1 (es) | 2009-10-21 |
RU2493826C2 (ru) | 2013-09-27 |
KR20120078754A (ko) | 2012-07-10 |
BRPI0815562A2 (pt) | 2015-02-18 |
PE20090476A1 (es) | 2009-05-12 |
US20100197629A1 (en) | 2010-08-05 |
AU2008274170A1 (en) | 2009-01-15 |
PE20130180A1 (es) | 2013-03-06 |
JP2010533146A (ja) | 2010-10-21 |
TW200911302A (en) | 2009-03-16 |
IL202961A (en) | 2013-10-31 |
CO6270204A2 (es) | 2011-04-20 |
MY147366A (en) | 2012-11-30 |
ZA200908993B (en) | 2010-09-29 |
EP2178503A1 (en) | 2010-04-28 |
US8445457B2 (en) | 2013-05-21 |
KR20100029829A (ko) | 2010-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR059359A1 (es) | Formulaciones farmaceuticas que contienen pleconaril | |
MA28921B1 (fr) | Derive heterocyclique azote et medicament le contenant en tant que principe actif | |
RS52367B (en) | GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES | |
AR059357A1 (es) | Formulaciones farmaceuticas | |
DE602005010788D1 (de) | Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
AR042066A1 (es) | Dispositivo conector | |
UY30759A1 (es) | Compuestos quimicos | |
CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
CL2008003595A1 (es) | Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central. | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
EA201200096A1 (ru) | Фармацевтическая композиция ингибитора протеазы вируса гепатита c | |
LTPA2019508I1 (lt) | Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui | |
CL2008001297A1 (es) | N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer. | |
ECSP109871A (es) | Soluciones farmacéuticas orales que contienen telbivudina | |
IN2012DN00359A (es) | ||
CO6311083A2 (es) | 4-((1r,3s)-6-cloro-3-fenilindan-1-il)-1,2,2-trimetilpiperazina para el tratamiento de la disfunción cognitiva | |
AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
NO20081559L (no) | Kit for parenteral administrering av medikamenter | |
DE602006012310D1 (de) | An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen | |
NO20070831L (no) | Middel for aktivering av tilfriskning fra dysfunksjon etter starten av sentralnevrologisk sykdom. | |
CY1119777T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα (1r,4r)-6'-φθοpo-n,n-διμεθυλ-4-φαινυλ-4',9'διυδρο-3'h-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,β]ινδολ]-4-αμινη και γκαμπαπεντινοειδες | |
ES2531241T3 (es) | Composición farmacéutica líquida estable a base de trazodona | |
AR033596A1 (es) | Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno | |
PA8682701A1 (es) | Formulacion de liberación prolongada de principios activos de medicamentos |